We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+9.48%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$34.5B
AUM Growth
+$1.76B
(+5.4%)
Cap. Flow
-$769M
Cap. Flow
% of AUM
-2.23%
Top 10 Holdings %
Top 10 Hldgs %
26.77%
Holding
1,963
New
176
Increased
1,051
Reduced
620
Closed
112
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Albemarle
ALB
|
+$68.7M |
| 2 |
GE HealthCare
GEHC
|
+$28.6M |
| 3 |
ON Semiconductor
ON
|
+$28.1M |
| 4 |
Caterpillar
CAT
|
+$22.6M |
| 5 |
IBM
IBM
|
+$20.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$94.9M |
| 2 |
Apple
AAPL
|
+$91M |
| 3 |
West Pharmaceutical
WST
|
+$69M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$61.8M |
| 5 |
Amazon
AMZN
|
+$55.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.36% |
| 2 | Industrials | 12.05% |
| 3 | Consumer Staples | 10.74% |
| 4 | Consumer Discretionary | 10.51% |
| 5 | Healthcare | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Caribou Biosciences
CRBU
$158M
| $48.3K | ﹤0.01% |
11,368
+538
| +5% | +$2.42K |
|
1777
FTAI Infrastructure
FIP
$508M
| $47.5K | ﹤0.01% |
+12,873
| New | +$41.8K |
|
1778
Accuray
ARAY
$27.7M
| $46.9K | ﹤0.01% |
+12,131
| New | +$42.1K |
|
1779
Gevo
GEVO
$421M
| $46.2K | ﹤0.01% |
30,415
+7,247
| +31% | +$9.37K |
|
|
SLGC
1780
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $45.4K | ﹤0.01% |
19,658
+1,530
| +8% | +$4.32K |
|
|
QUOT
1781
DELISTED
Quotient Technology Inc
QUOT
| $45.2K | ﹤0.01% |
11,772
+1,108
| +10% | +$3.44K |
|
|
CNSL
1782
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $44.4K | ﹤0.01% |
11,604
+845
| +8% | +$3.05K |
|
|
EU
1783
enCore Energy
EU
$225M
| $44.4K | ﹤0.01% |
+18,418
| New | +$41.1K |
|
|
CANO
1784
DELISTED
Cano Health, Inc.
CANO
| $43.2K | ﹤0.01% |
311
+120
| +63% | +$15.4K |
|
|
SFIX
1785
Stitch Fix
SFIX
$464M
| $42.3K | ﹤0.01% |
+10,975
| New | +$41.6K |
|
|
TDAY
1786
USA Today Co
TDAY
$1.23B
| $42.2K | ﹤0.01% |
18,766
-2,170
| -10% | -$4.33K |
|
1787
Humacyte
HUMA
$170M
| $41.9K | ﹤0.01% |
14,650
+582
| +4% | +$2.1K |
|
1788
Butterfly Network
BFLY
$1.72B
| $41.7K | ﹤0.01% |
18,150
+2,506
| +16% | +$5.6K |
|
|
TWOU
1789
DELISTED
2U Inc
TWOU
| $41.5K | ﹤0.01% |
343
-18
| -5% | -$2.39K |
|
1790
SES AI
SES
$185M
| $39.6K | ﹤0.01% |
+16,240
| New | +$31.5K |
|
1791
Karyopharm Therapeutics
KPTI
$160M
| $39.6K | ﹤0.01% |
1,474
+339
| +30% | +$14.6K |
|
1792
Precigen
PGEN
$1.93B
| $39.2K | ﹤0.01% |
34,104
+2,344
| +7% | +$2.77K |
|
|
KLRS
1793
Kalaris Therapeutics
KLRS
$89.7M
| $39.1K | ﹤0.01% |
500
+59
| +13% | +$5.61K |
|
|
SGMO
1794
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $38.8K | ﹤0.01% |
29,875
+2,444
| +9% | +$3.34K |
|
|
NVTA
1795
DELISTED
Invitae Corporation
NVTA
| $38.6K | ﹤0.01% |
34,181
+5,480
| +19% | +$6.91K |
|
1796
Tango Therapeutics
TNGX
$4.36B
| $38.3K | ﹤0.01% |
11,526
-76
| -0.7% | -$273 |
|
1797
Compass Therapeutics
CMPX
$375M
| $37.7K | ﹤0.01% |
+11,868
| New | +$37.3K |
|
1798
Quantum-Si Incorporated
QSI
$169M
| $37.5K | ﹤0.01% |
20,930
+1,868
| +10% | +$2.93K |
|
1799
Codexis
CDXS
$135M
| $36.4K | ﹤0.01% |
12,994
+1,216
| +10% | +$3.93K |
|
|
TSP
1800
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $35.7K | ﹤0.01% |
21,484
+4,827
| +29% | +$7.81K |
|
Similar funds
ProShare Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, ProShare Advisors held 1,963 positions worth $34.5B, up 5.4% from $32.7B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
ProShare Advisors's Q2 2023 filing shows 176 new, 1,051 increased, 620 reduced and 112 closed positions. Its largest new stake was Artesian Resources: 162,581 shares worth $7.68M. The largest sale was Microsoft, an estimated $94.9M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Industrials and Consumer Staples.
- ProShare Advisors's largest Q2 2023 buy was Artesian Resources: 162,581 shares worth $7.68M.
- ProShare Advisors added most to Albemarle in Q2 2023, an estimated $68.7M increase.
- ProShare Advisors's biggest Q2 2023 reduction was Microsoft, cutting an estimated $94.9M.
- ProShare Advisors fully exited Rivian in Q2 2023, selling an estimated $11.9M.
- ProShare Advisors's ten largest holdings make up 27% of its $34.5B portfolio in Q2 2023.
- ProShare Advisors opened 176 new positions and closed 112 in Q2 2023.
- ProShare Advisors's portfolio value rose 5.4% quarter-over-quarter to $34.5B.
Based on ProShare Advisors's 13F filing for Q2 2023, filed 10 Aug 2023.